Patient characteristics associated with complications during neonatal intubations

Pediatr Pulmonol. 2021 Aug;56(8):2576-2582. doi: 10.1002/ppul.25453. Epub 2021 May 13.

Abstract

Introduction: Complications of neonatal intubation are known to be increased with emergent intubations, increased number of attempts, unstable hemodynamics, or ventilation failure; and decreased with use of paralytic medication and videolaryngoscopy. Patient characteristics associated with complications are not well understood.

Design/methods: A retrospective cohort study was performed of neonates who underwent intubation between January 2017 and June 2019. Patient characteristics of infants with and without complications were compared. Complications included common adverse events and abnormal vital sign changes occurring during intubation.

Results: A total of 467 intubation encounters in 352 infants were included with median gestational age (GA) at birth of 29 weeks, postmenstrual age (PMA) 33 weeks at intubation, and median weight 1795 g. 41.5% of infants had complications and 58.5% of infants did not. Infants with complications compared to infants without had a median FiO2 of 0.50 versus 0.45 (p = .183), median GA at birth of 29 versus 31 weeks (p < .001), median PMA of 32 weeks versus 33.0 weeks (p = .352), median weight of 1540 g versus 1970g (p = .091), and median chronological age of 3 days versus 1 day (p = .001). Generalized Estimating Equations controlling for administration of paralytic indicated decreased complications in infants ≤21.5 days in chronological age (OR, 0.45; 95% CI, 0.30-0.69) and increased complications in infants ≤1565 g (OR, 1.52; 95% CI, 1.04-2.23).

Conclusion: Patient characteristics associated with an increased rate of complications included chronological age and weight. Further study is needed to reduce complications.

Keywords: adverse events; critical care; neonatal intubation; neonatal pulmonary medicine; respiratory technology.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Gestational Age
  • Humans
  • Infant
  • Infant, Newborn
  • Intubation, Intratracheal* / adverse effects
  • Retrospective Studies